Chinese advanced fusion-dependent lung cancer patients: Molecular spectrum and treatment options using next generation sequencing-A multicenter study (Yangtze River Delta Lung Cancer Cooperation Group-001).

doi:10.1200/JCO.2021.39.15_suppl.e21036

HFCAS OpenIR

	Chinese advanced fusion-dependent lung cancer patients: Molecular spectrum and treatment options using next generation sequencing-A multicenter study (Yangtze River Delta Lung Cancer Cooperation Group-001).
	Wang, Wen Xian ; Xu, Chun-Wei ; Li, Ziming ; Song, Zhengbo ; Fang, Wenfeng ; Miao, Liyun ; Zhu, You-Cai ; Zhang, Shirong ; Song, Bin-Bin ; Shi, Xue-Fei ; Yu, Genhua ; Chen, Huafei ; Rao, Chuangzhou ; Huang, Jianhui ; Zhan, Ping ; Liu, Hongbing ; Wang, Qian ; Lv, Tang-Feng ; Song, Yong ; Lu, Shun
	2021-05-20
发表期刊	JOURNAL OF CLINICAL ONCOLOGY
ISSN	0732-183X
DOI	10.1200/JCO.2021.39.15_suppl.e21036
收录类别	SCI
语种	英语
WOS研究方向	Oncology
WOS类目	Oncology
WOS记录号	WOS:000708120305037
出版者	LIPPINCOTT WILLIAMS & WILKINS
引用统计	被引频次：1[WOS] [WOS记录] [WOS相关记录]
文献类型	期刊论文
条目标识符	http://ir.hfcas.ac.cn:8080/handle/334002/126513
专题	中国科学院合肥物质科学研究院
作者单位	1.Univ Chinese Acad Sci, Chinese Acad Sci, Inst Canc Res & Basic Med Sci, Zhejiang Canc Hosp,Dept Med Oncol,Canc Hosp, Hangzhou, Peoples R China 2.Nanjing Univ, Dept Resp Med, Affiliated Jinling Hosp, Med Sch, Nanjing, Peoples R China 3.Shanghai Jiao Tong Univ, Shanghai Lung Canc Ctr, Shanghai Chest Hosp, Shanghai, Peoples R China 4.Zhejiang Canc Hosp, Hangzhou, Peoples R China 5.Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr, Guangzhou, Peoples R China 6.Nanjing Univ, Med Sch, Affiliated Hosp, Nanjing Drum Tower Hosp, Nanjing, Peoples R China 7.Zhejiang Rongjun Hosp, Jiaxing, Peoples R China 8.Zhejiang Univ, Key Lab Clin Canc Pharmacol & Toxicol Res Zhejian, Affiliated Hangzhou Peoples Hosp 1, Translat Med Res Ctr,Sch Med, Hangzhou, Peoples R China 9.Jiaxing Univ, Dept Med Oncol, Affiliated Hosp, Jiaxing, Peoples R China 10.Huzhou Cent Hosp, Dept Resp Med, Huzhou, Peoples R China 11.Zhebei Mingzhou Hosp, Huzhou, Peoples R China 12.Ningbo 2 Hosp, Dept Radiotherapy, Ningbo, Peoples R China 13.Zhejiang Univ, Lishui Hosp, Lishui Cent Hosp, Lishui, Peoples R China 14.Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp Med, Nanjing, Peoples R China 15.Nanjing Univ Chinese Med, Affiliated Hosp, Dept Resp Med, Nanjing, Peoples R China 16.Jinling Hosp, Nanjing Gen Hosp Nanjing Mil Command NGH, Nanjing, Peoples R China 17.Shanghai JiaoTong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China
推荐引用方式 GB/T 7714	Wang, Wen Xian,Xu, Chun-Wei,Li, Ziming,et al. Chinese advanced fusion-dependent lung cancer patients: Molecular spectrum and treatment options using next generation sequencing-A multicenter study (Yangtze River Delta Lung Cancer Cooperation Group-001).[J]. JOURNAL OF CLINICAL ONCOLOGY,2021,39.
APA	Wang, Wen Xian.,Xu, Chun-Wei.,Li, Ziming.,Song, Zhengbo.,Fang, Wenfeng.,...&Lu, Shun.(2021).Chinese advanced fusion-dependent lung cancer patients: Molecular spectrum and treatment options using next generation sequencing-A multicenter study (Yangtze River Delta Lung Cancer Cooperation Group-001)..JOURNAL OF CLINICAL ONCOLOGY,39.
MLA	Wang, Wen Xian,et al."Chinese advanced fusion-dependent lung cancer patients: Molecular spectrum and treatment options using next generation sequencing-A multicenter study (Yangtze River Delta Lung Cancer Cooperation Group-001).".JOURNAL OF CLINICAL ONCOLOGY 39(2021).